1-3 of 3
Herbert Faleck
Close
Sort by
Journal Articles

Human Placenta-Derived Adherent Cells Delivered Intralesionally Inhibit Myeloma Bone Disease and Tumor Growth, While Intravenously Are Capable of Trafficking to Myelomatous Bone.

Xin Li, PhD, Wen Ling, MS, Angela Pennisi, MD, Yuping Wang, PhD, Sharmin Khan, MS, Mohammad Heidaran, PhD, Ajai Pal, PhD, Xiaokui Zhang, PhD, Shuyang He, PhD, Andy Zeitlin, Stewart Abbot, PhD, Herbert Faleck, DO, Robert Hariri, MD, PhD., John Shaughnessy, Jr., PhD, Frits van Rhee, MD, PhD, Bijay Nair, MD, MPH, Bart Barlogie, MD, PhD, Joshua Epstein, DSc, Shmuel Yaccoby, PhD
Journal: Blood
Blood (2010) 116 (21): 3717.
https://doi.org/10.1182/blood.V116.21.3717.3717
Published: 2010
Journal Articles

Human Placenta-Derived Adherent Stem Cells Prevent Bone Loss and Stimulate Bone Formation in Myelomatous Bones, and Suppress Growth of Primary Multiple Myeloma

Xin Li, Wen Ling, Angela Pennisi, Jianmei Chen, Sharmin Khan, Mohammad Heidaran, Herbert Faleck, Robert Hariri, John Shaughnessy, Frits van Rhee, Joshua Epstein, Bart Barlogie, Shmuel Yaccoby
Journal: Blood
Blood (2008) 112 (11): 646.
https://doi.org/10.1182/blood.V112.11.646.646
Published: 2008
Journal Articles

A Multicenter, Single-Arm, Open-Label Study To Evaluate the Efficacy and Safety of Single-Agent Lenalidomide in Patients with Relapsed and Refractory Multiple Myeloma; Prelininary Results.

Paul Richardson, MD, Sundar Jagannath, MD, Mohamad Hussein, MD, James Berenson, MD, Seema Singhal, MD, David Irwin, MD, Stephanie F. Williams, MD, William Bensinger, MD, Ashraf Z. Badros, MD, Robert Vescio, MD, Laurie Kenvin, BSN, Zhinuan Yu, PhD, Marta Olesnyckyj, RN, BSN, Herbert Faleck, DO, Jerome Zeldis, MD, Robert Knight, MD, Kenneth C. Anderson, MD
Journal: Blood
Blood (2005) 106 (11): 1565.
https://doi.org/10.1182/blood.V106.11.1565.1565
Published: 2005